Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
Trials. 2019 Dec 13;20(1):721.
doi: 10.1186/s13063-019-3940-0.